MRK

3 “Dogs of the Dow” Paying Up to 4.3% (CVX, PFE, VZ)

The Dogs of the Dow are back, and we've highlighted three of them for your dividend stock portfolio consideration More 

Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Breakup Gold

Valeant Pharmaceuticals' (VRX) asset sales could be the start of a breakup. Speculators who get into VRX stock now can still reap rewards. More 

4 Reasons Why Pfizer Inc. Stock (PFE) Could be a Great Pick in 2017

Pfizer's shares surpassed that of large-cap pharma industry in 2016. PFE stock rose 0.6% in 2016, and here's why 2017 should be just as good More 

Merck & Co., Inc. (MRK) Stock Is Defying the Bears!

Merck & Co. (MRK) has gifted traders with an early 2017 trading signal. Thanks to Tuesday's bounce, MRK stock could enjoy new buying pressure. More 

Buy the Best Dividend Stocks Today at a 16% Discount

You don't have to buy a stock for the price you see on Yahoo Finance. You can buy some of the best large cap dividend stocks in this CEF... More 

Value Battle: Pfizer Inc. (PFE) vs. Merck & Co., Inc. (MRK)

Pfizer (PFE) hasn't done very well in 2016, making its value battle with Merck (MRK) an interesting proposition.   More 

2 Ways To Profit From Accelerated R&D Spending

A marked increase in R&D spending bodes well for the economy and these two fund stocks to consider... More